Does the timing of esophagectomy after chemoradiation affect outcome? - Wikidata - wikimedia - TriplyDB

Does the timing of esophagectomy after chemoradiation affect outcome?

Does the timing of esophagectomy after chemoradiation affect outcome?

http://www.wikidata.org/entity/Q33699376

about

Current management of esophageal cancer Esophageal cancer management controversies: Radiation oncology point of view Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making.Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol.The effect of time interval on esophagectomy after neoadjuvant treatment Introduction of Minimally Invasive Esophagectomy in a Community Teaching Hospital.A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer Current and future options for treating esophageal cancer: a paradigm shift toward organ-sparing therapies.Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.When to resect following neoadjuvant therapy for esophageal cancer-issues and limitations in addressing this decision [Timing of esophagectomy in multimodal therapy of esophageal cancer: Impact of time interval between neoadjuvant therapy and surgery on outcome and response].Active surveillance in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal or junctional cancer.Complete pathologic response is independent of the timing of esophagectomy following neoadjuvant chemoradiation for esophageal cancer.Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis.Is there an optimal surgery time after endoscopic resection in early gastric cancer?Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer.Surveillance versus esophagectomy in esophageal cancer patients with a clinical complete response after induction chemoradiation.Clinical predictors of pathologically response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma: long term outcomes of a phase II study

P2860

Q33658207-7E9B106C-FABB-4D29-9D7A-CE32A68BEBCB Q34049113-5FD645C7-82C1-4331-813C-3065AD2684C5 Q34382399-142F45C3-1794-4ECF-992E-83528E90AAFE Q34836622-24244FA3-BDB0-4A6B-BA7F-4D6E875B7652 Q35830542-264BCA94-56D7-4024-A650-EF2235F4B13A Q35922472-D99453CE-5E60-4EE7-A8B6-637D8898B6BC Q36790065-78BB6749-A282-468F-97A0-DA46FB3E2D0B Q37606911-06D45EF4-8095-4875-8975-8D7C58A22BEE Q37608370-3E757C86-978E-4811-8DD0-9E90C1C041C4 Q38072916-C612129F-14E8-4DE5-B3F2-DF125F8A69BD Q38626465-60993495-B6CE-4091-9F85-91E81E4A4A7B Q42357345-73DFB69E-C6CF-4EEB-9BE1-31EFEC4D9BB8 Q44802763-A10763A7-7BCD-43F1-A801-A9749B1C5644 Q47960613-AF4A86C5-BB6E-44AB-9507-DF51E4A829B5 Q52725075-58C908C4-6F28-493B-9276-33E02F6B2AC3 Q52852297-F5A2715C-DD95-4555-94B3-99829E47D03E Q53313340-8315A80F-3B96-4142-BAB3-E6BA896383A4 Q54652098-1A7F42E2-819D-41CD-8F0D-81223BEAA3E6 Q55230734-634436C1-F108-423E-9177-EA105031C117 Q58770960-3046DE9C-9D4B-4F50-A261-6BA7D048A8B8

P2860

Does the timing of esophagectomy after chemoradiation affect outcome?

http://www.wikidata.org/entity/Q33699376

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Does the timing of esophagectomy after chemoradiation affect outcome?

@ast

Does the timing of esophagectomy after chemoradiation affect outcome?

@en

type

label

Does the timing of esophagectomy after chemoradiation affect outcome?

@ast

Does the timing of esophagectomy after chemoradiation affect outcome?

@en

prefLabel

Does the timing of esophagectomy after chemoradiation affect outcome?

@ast

Does the timing of esophagectomy after chemoradiation affect outcome?

@en

P1433

Q33699376-0CAFDF32-1490-45CA-890C-6659B12FA203

P1476

Q33699376-7DCABA86-8FDA-4A74-B75E-915F4A9AE5CA

P2093

Q33699376-28808D00-44FF-495A-BF39-6E465083A0A6

Q33699376-2C032434-DA94-445F-BA1E-4C0B3D7E885A

Q33699376-452CCD14-41EA-456B-8D20-787D44E096ED

Q33699376-4AA55485-978E-43EA-84D3-BC6EA4E534C7

Q33699376-5D647209-FFBE-449F-B9E6-55FB66CD96C4

Q33699376-5E6A8307-663D-412B-8FF1-5EBE2F7879F4

Q33699376-729F8166-1648-4824-AF0D-3C1376A26403

Q33699376-7DAFEAD7-6F94-435D-89A9-162DD4B5B5D8

Q33699376-92D625FA-F060-4AB8-88BA-4D5367C837E8

Q33699376-A0C51FE5-7922-45A1-9D90-CB2DBA4BC84F

P2860

Q33699376-20C4709F-EC9B-4038-864C-DF4DF40FBB81

Q33699376-24DE4708-973B-42F3-B489-9A4873E94889

Q33699376-2E25CFFC-D76A-4E35-9E4D-D5E4D774ECDA

Q33699376-5E25572F-874E-4E90-B2A7-ED31F3111792

Q33699376-710C44AC-1358-4D39-8A74-61E74FC54352

Q33699376-7DD7DA05-F8AE-4EF4-80CF-BDF05C912AD1

Q33699376-8A240AE4-BEF5-4120-91A4-884A9F20462E

Q33699376-9BCF05C7-1167-4030-9408-105E804F9463

Q33699376-9C9B50A7-44C2-4485-94F5-B4E2F79D6A88

Q33699376-A209EF78-DA4A-48EE-BBD1-50DC1F33C954

P304

Q33699376-B7493FAA-AD06-4D6E-9FDB-BBEEE1FF968D

P31

Q33699376-58499425-BE35-4909-BC92-D7E7DBDC967F

P356

Q33699376-D049E148-A96E-4475-BF15-D02227B071AA

P407

Q33699376-8ED5A4DE-93A5-4D03-A024-D76695755B0A

P433

Q33699376-B9846469-7919-467A-9173-B9A2AE97DF86

P478

Q33699376-2AAB6A54-C3A9-4CD8-B117-6E924A49ABB1

P577

Q33699376-CAA6CF45-513A-4CC3-AA5E-1D269ED55AAA

P698

Q33699376-6839B104-06A0-4632-8E78-3EC7FC413FA6

P921

Q33699376-AFC5B154-BBD0-4835-8F38-43A05E761A2C

P932

Q33699376-E3613F4B-24C9-44AA-9321-FC2E5AFB354A

P356

J.ATHORACSUR.2011.05.021

P1433

The Annals of Thoracic Surgery

P1476

Does the timing of esophagectomy after chemoradiation affect outcome?

@en

P2093

Ara A Vaporciyan

http://www.w3.org/2001/XMLSchema#string

Arlene M Correa

http://www.w3.org/2001/XMLSchema#string

David C Rice

http://www.w3.org/2001/XMLSchema#string

Dipen M Maru

http://www.w3.org/2001/XMLSchema#string

Edith M Marom

http://www.w3.org/2001/XMLSchema#string

Garrett L Walsh

http://www.w3.org/2001/XMLSchema#string

Jack A Roth

http://www.w3.org/2001/XMLSchema#string

Jae Y Kim

http://www.w3.org/2001/XMLSchema#string

Jaffer A Ajani

http://www.w3.org/2001/XMLSchema#string

James Welsh

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer.

Current management for late normal tissue injury: radiation-induced fibrosis and necrosis.

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer.

Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial.

Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy.

Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer.

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.

P304

207-12; discussion 212-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ATHORACSUR.2011.05.021

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21962263

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4041623

http://www.w3.org/2001/XMLSchema#string